RCKT
Rocket Pharmaceuticals Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$3.070
Máximo
$3.070
Mínimo
$3.070
Volumen
3.11M
Fundamentos de la Empresa
Estadísticas de Negociación
Noticias Relacionadas
Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $11
Canaccord Genuity analyst Whitney Ijem maintains Rocket Pharmaceuticals with a Buy and lowers the price target from $34 to $11.
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
B of A Securities Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $9
B of A Securities analyst Greg Harrison maintains Rocket Pharmaceuticals with a Buy and lowers the price target from $32 to $9.
BMO Capital Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $8
BMO Capital analyst Kostas Biliouris maintains Rocket Pharmaceuticals with a Outperform and lowers the price target from $30 to $8.
Scotiabank Maintains Sector Outperform on Rocket Pharmaceuticals, Lowers Price Target to $19
Scotiabank analyst Greg Harrison maintains Rocket Pharmaceuticals with a Sector Outperform and lowers the price target from $51 to $19.
Leerink Partners Downgrades Rocket Pharmaceuticals to Market Perform, Lowers Price Target to $8
Leerink Partners analyst Mani Foroohar downgrades Rocket Pharmaceuticals from Outperform to Market Perform and lowers the price target from $37 to $8.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.